5-176238543-G-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001308195.2(SIMC1):c.35G>A(p.Gly12Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,331,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001308195.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIMC1 | NM_001308195.2 | c.35G>A | p.Gly12Asp | missense_variant | Exon 1 of 10 | ENST00000429602.7 | NP_001295124.1 | |
SIMC1 | NM_198567.6 | c.35G>A | p.Gly12Asp | missense_variant | Exon 1 of 9 | NP_940969.3 | ||
SIMC1 | NM_001308196.2 | c.-231G>A | 5_prime_UTR_variant | Exon 1 of 12 | NP_001295125.1 | |||
SIMC1 | NR_131772.2 | n.120G>A | non_coding_transcript_exon_variant | Exon 1 of 10 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000398 AC: 6AN: 150886Hom.: 0 Cov.: 21 show subpopulations
GnomAD4 exome AF: 0.000112 AC: 132AN: 1180390Hom.: 0 Cov.: 30 AF XY: 0.000124 AC XY: 72AN XY: 578654 show subpopulations
GnomAD4 genome AF: 0.0000398 AC: 6AN: 150886Hom.: 0 Cov.: 21 AF XY: 0.0000815 AC XY: 6AN XY: 73626 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.35G>A (p.G12D) alteration is located in exon 1 (coding exon 1) of the SIMC1 gene. This alteration results from a G to A substitution at nucleotide position 35, causing the glycine (G) at amino acid position 12 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at